BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31684108)

  • 21. High-mobility-group A2 overexpression provokes a poor prognosis of gastric cancer through the epithelial-mesenchymal transition.
    Lee J; Ha S; Jung CK; Lee HH
    Int J Oncol; 2015; 46(6):2431-8. PubMed ID: 25845850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The chromatin structuring protein HMGA2 influences human subtelomere stability and cancer chemosensitivity.
    Ahmed SM; Ramani PD; Wong SQR; Zhao X; Ivanyi-Nagy R; Leong TC; Chua C; Li Z; Hentze H; Tan IB; Yan J; DasGupta R; Dröge P
    PLoS One; 2019; 14(5):e0215696. PubMed ID: 31067275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development.
    Ma J; Li D; Kong FF; Yang D; Yang H; Ma XX
    J Exp Clin Cancer Res; 2018 Feb; 37(1):19. PubMed ID: 29391048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HMGA2 is associated with the aggressiveness of tongue squamous cell carcinoma.
    Zhang H; Tang Z; Deng C; He Y; Wu F; Liu O; Hu C
    Oral Dis; 2017 Mar; 23(2):255-264. PubMed ID: 27809392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antileukemia Effect of Ciclopirox Olamine Is Mediated by Downregulation of Intracellular Ferritin and Inhibition β-Catenin-c-Myc Signaling Pathway in Glucocorticoid Resistant T-ALL Cell Lines.
    Wu J; Liu H; Zhang G; Gu L; Zhang Y; Gao J; Wei Y; Ma Z
    PLoS One; 2016; 11(8):e0161509. PubMed ID: 27551974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HSP90 inhibitor NVP-AUY922 enhances TRAIL-induced apoptosis by suppressing the JAK2-STAT3-Mcl-1 signal transduction pathway in colorectal cancer cells.
    Lee DH; Sung KS; Bartlett DL; Kwon YT; Lee YJ
    Cell Signal; 2015 Feb; 27(2):293-305. PubMed ID: 25446253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of let-7a-5p predicts lymph node metastasis and prognosis in colorectal cancer: Implications for chemotherapy.
    Liu TP; Huang CC; Yeh KT; Ke TW; Wei PL; Yang JR; Cheng YW
    Surg Oncol; 2016 Dec; 25(4):429-434. PubMed ID: 27262492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fosciclopirox suppresses growth of high-grade urothelial cancer by targeting the γ-secretase complex.
    Weir SJ; Dandawate P; Standing D; Bhattacharyya S; Ramamoorthy P; Rangarajan P; Wood R; Brinker AE; Woolbright BL; Tanol M; Ham T; McCulloch W; Dalton M; Reed GA; Baltezor MJ; Jensen RA; Taylor JA; Anant S
    Cell Death Dis; 2021 May; 12(6):562. PubMed ID: 34059639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dicoumarol suppresses HMGA2-mediated oncogenic capacities and inhibits cell proliferation by inducing apoptosis in colon cancer.
    Chen CH; Hsieh YC; Yang PM; Liu YR; Cho EC
    Biochem Biophys Res Commun; 2020 Apr; 524(4):1003-1009. PubMed ID: 32063361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knockdown of HMGA2 regulates the level of autophagy via interactions between MSI2 and Beclin1 to inhibit NF1-associated malignant peripheral nerve sheath tumour growth.
    Yang K; Guo W; Ren T; Huang Y; Han Y; Zhang H; Zhang J
    J Exp Clin Cancer Res; 2019 May; 38(1):185. PubMed ID: 31053152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting of high mobility group A2 by small interfering RNA-loaded nanoliposome-induced apoptosis and migration inhibition in gastrointestinal cancer cells.
    Mohammadi A; Mansoori B; Savadi P; Khaze V; Minouei M; McMillan NAJ; Hallaj-Nezhadi S; Baradaran B
    J Cell Biochem; 2019 Jun; 120(6):9203-9212. PubMed ID: 30507008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The chromatin-modifying protein HMGA2 promotes atypical teratoid/rhabdoid cell tumorigenicity.
    Kaur H; Hütt-Cabezas M; Weingart MF; Xu J; Kuwahara Y; Erdreich-Epstein A; Weissman BE; Eberhart CG; Raabe EH
    J Neuropathol Exp Neurol; 2015 Feb; 74(2):177-85. PubMed ID: 25575139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells.
    Eberhard Y; McDermott SP; Wang X; Gronda M; Venugopal A; Wood TE; Hurren R; Datti A; Batey RA; Wrana J; Antholine WE; Dick JE; Schimmer AD
    Blood; 2009 Oct; 114(14):3064-73. PubMed ID: 19589922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression.
    Li Y; Zhao Z; Xu C; Zhou Z; Zhu Z; You T
    Cancer Lett; 2014 Dec; 355(1):130-40. PubMed ID: 25218351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HMGA2 gene is a promising target for ovarian cancer silencing therapy.
    Malek A; Bakhidze E; Noske A; Sers C; Aigner A; Schäfer R; Tchernitsa O
    Int J Cancer; 2008 Jul; 123(2):348-356. PubMed ID: 18452175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p14Arf acts as an antagonist of HMGA2 in senescence of mesenchymal stem cells-implications for benign tumorigenesis.
    Markowski DN; Winter N; Meyer F; von Ahsen I; Wenk H; Nolte I; Bullerdiek J
    Genes Chromosomes Cancer; 2011 Jul; 50(7):489-98. PubMed ID: 21456046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HMGA2 Modulates the TGFβ/Smad, TGFβ/ERK and Notch Signaling Pathways in Human Lens Epithelial-Mesenchymal Transition.
    Hou M; Bao X; Luo F; Chen X; Liu L; Wu M
    Curr Mol Med; 2018; 18(2):71-82. PubMed ID: 29974827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated HMGA2 expression is associated with cancer aggressiveness and predicts poor outcome in breast cancer.
    Wu J; Zhang S; Shan J; Hu Z; Liu X; Chen L; Ren X; Yao L; Sheng H; Li L; Ann D; Yen Y; Wang J; Wang X
    Cancer Lett; 2016 Jul; 376(2):284-92. PubMed ID: 27063096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear Localization Signal-Enhanced Polyurethane-Short Branch Polyethylenimine-Mediated Delivery of Let-7a Inhibited Cancer Stem-Like Properties by Targeting the 3'-UTR of HMGA2 in Anaplastic Astrocytoma.
    Yang MY; Chen MT; Huang PI; Wang CY; Chang YC; Yang YP; Lo WL; Sung WH; Liao YW; Lee YY; Chang YL; Tseng LM; Chen YW; Ma HI
    Cell Transplant; 2015; 24(8):1431-50. PubMed ID: 24898358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HMGA2 as a Critical Regulator in Cancer Development.
    Mansoori B; Mohammadi A; Ditzel HJ; Duijf PHG; Khaze V; Gjerstorff MF; Baradaran B
    Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33668453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.